Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
about
Alteration of energy substrates and ROS production in diabetic cardiomyopathyControl of hyperglycaemia in paediatric intensive care (CHiP): study protocolThe threshold of admission glycemia as a predictor of adverse events in diabetic and non-diabetic patients with acute coronary syndrome.Relationship between admitting nonfasting blood glucose and in-hospital mortality stratified by diabetes mellitus among acute coronary syndrome patients in oman.Acute Phase Hyperglycemia among Patients Hospitalized with Acute Coronary Syndrome: Prevalence and Prognostic SignificanceThe effect of muscle power training with elastic band on blood glucose, cytokine, and physical function in elderly women with hyperglycemia.Acute Hepatic Insulin Resistance Contributes to Hyperglycemia in Rats Following Myocardial Infarction.Murine hyperglycemic vasculopathy and cardiomyopathy: whole-genome gene expression analysis predicts cellular targets and regulatory networks influenced by mannose binding lectinAdmission hyperglycemia and adverse outcomes in diabetic and non-diabetic patients with non-ST-elevation myocardial infarction undergoing percutaneous coronary intervention.Is admission blood glucose concentration a more powerful predictor of mortality after myocardial infarction than diabetes diagnosis? A retrospective cohort study.The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes.Acute insulin resistance in myocardial ischemia: causes and consequences.Oxidative stress as the leading cause of acute myocardial infarction in diabetics.Analysis of factors related to short-term prognosis in patients undergoing percutaneous coronary intervention for acute myocardial infarctionHyperglycemia is associated with enhanced thrombin formation, platelet activation, and fibrin clot resistance to lysis in patients with acute coronary syndrome.Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein.Fasting or caloric restriction for healthy aging.Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options.Predicting the no-reflow phenomenon following successful percutaneous coronary intervention.Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications.Admission hyperglycemia predicts poorer short- and long-term outcomes after primary percutaneous coronary intervention for ST-elevation myocardial infarction.Evaluation of Ischemia-Modified Albumin, Malondialdehyde, and Advanced Oxidative Protein Products as Markers of Vascular Injury in Diabetic Nephropathy.Effects of Short-term Renovascular Hypertension and Type 2 Diabetes on Cardiac Functions in Rats.PKC-mediated toxicity of elevated glucose concentration on cardiomyocyte function.Effects of oral glucose load on endothelial function and on insulin and glucose fluctuations in healthy individuals.Hyperglycaemia at admission in acute coronary syndrome patients: prognostic value in diabetics and non-diabetics.Hydroalcoholic extract of Allium eriophyllum leaves attenuates cardiac impairment in rats with simultaneous type 2 diabetes and renal hypertension.Hyperglycemia and risk of ventricular tachycardia among patients hospitalized with acute myocardial infarction
P2860
Q27014882-974C7939-51B9-410C-B771-94EC15C86328Q33529877-E9631BA0-1FE3-4797-B991-5E7684A46640Q33860208-9E851C98-074D-4D7E-9EA7-C906596D4B22Q35069085-3BAF6AD4-8DAE-48D3-8DE5-948F7C8C057EQ35324130-002C5956-FDAE-4990-90F7-69CFDD10127EQ35583525-3ADED23C-022C-476F-A3A4-6A84F25B7519Q35707124-5FA5576A-BA4D-4AFA-A93F-8019B899943FQ35777842-218C88F7-6732-4B6D-B946-8D99F431534AQ36240725-511ADA93-8B30-49FE-8199-BB87EEC03034Q36307110-F1092EF8-CB3D-4D63-8683-70040A28EF1AQ36333927-E2483859-BFAE-4927-A2D4-37D3B7D3CC5FQ36588698-994CE892-B769-4AF8-B50B-E4A30A01C404Q36589368-58A17F46-C3B4-4385-B4CE-5976C8930FB8Q36769020-CAE7E8D1-0A1C-4594-867B-340946FA6EB0Q36807512-FB3612BB-E803-4085-B0D3-C5E54809C6C1Q37197718-090D9713-3FFD-426E-A701-2D745CA73C09Q37295345-DC359597-7069-496E-B3B3-826D18FA4520Q37573674-FDD1DC4A-38EA-4841-853B-B34DFC90776AQ37762321-30D80899-BD6F-42D2-A5B4-09F6EE1EA798Q37765290-8662A232-362A-4FF2-BDC9-0AA658367409Q38551004-64EDC2BF-1598-4BE0-8210-D51B4F9F1BD3Q39719274-3EF59A48-9D80-4AD6-869A-A5D0D4D4DC1CQ40915092-D11A29E2-D9F4-4BDA-9688-5617FC8D0C68Q41879374-89745580-7B72-49B0-8C07-48473E3FF2B9Q42461046-520E424E-A8BA-41AD-8DDB-423DD3AB6BFBQ42604482-5EDD9C79-ADC7-41ED-9945-9FB7BF6211E3Q43181353-CEBD81A9-97E3-42B0-833D-98AF04AD07E4Q43238993-2A9393F8-B006-4645-84A7-58567DCB6151Q57809686-6E589150-1711-467D-A5B2-48FDB86A540F
P2860
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
@ast
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
@en
type
label
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
@ast
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
@en
prefLabel
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
@ast
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
@en
P2860
P921
P356
P1476
Acute hyperglycaemia: a 'new' risk factor during myocardial infarction.
@en
P2860
P304
P356
10.1093/EURHEARTJ/EHI049
P577
2004-11-30T00:00:00Z